Arcay, A. Et Al. 2018. Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers. 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Düsseldorf, Germany).

Arcay, A., Yilmaz, N., & Aydin, F., (2018). Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers . 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany

Arcay, A., N. Yilmaz, And F. Aydin. "Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers," 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 2018

Arcay, A. Et Al. "Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany, 2018

Arcay, A. Yilmaz, N. And Aydin, F. (2018) . "Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers." 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Düsseldorf, Germany.

@conferencepaper{conferencepaper, author={A. Arcay Et Al. }, title={Clinical Role of FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Tumor Markers}, congress name={31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Düsseldorf}, country={Germany}, year={2018}}